Wieslaw Swietnicki

Wroclaw, Lower Silesian District, Poland Poland

Principal Investigator

Education

Development of inhibitors of pathogenic E. coli. Current stage: lead optimization. I’ll be presenting at the In Silico Drug Discovery Conference, which takes place December 3-4, 2014 at NC Biotech’s Hamner Conference Center. Register to hear my discussion on design of small molecule inhibitors of type III secretion system in E. coli. Learn more at www.insiliconf.org. CNBC link: http://www.cnbc.com/id/102010368. Patent application PL409676 has been filed with the Polish Patent Office. Details will be public in April 2016. Patent subject is development of antibacterial compounds. A second project is on development of efflux pump inhibitors for chemotherapy. Goal of the project is to d...